Cambridge Cognition really exciting position and pipeline of opportunities (Interview)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk to discuss its interim results. Matthew takes us through the highlights, having seen major contract wins across all product families and at all stages of clinical development expands on the company offering, how the company has been impacted by Covid-19 and describes the outlook for COG.

Cambridge Cognition Holdings and its subsidiaries develops and markets digital solutions to assess brain health for sale worldwide, principally in the UK, the US and Europe.

You might also enjoy reading  Cambridge Cognition looking forward to a successful full year for 2021 (LON:COG)
Find more news, interviews, share price & company profile here for:
Cambridge Cognition Holdings plc

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Cambridge Cognition
Cambridge Cognition really exciting position and pipeline of opportunities (Interview)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions